Table 4.
Multivariate Cox regression analyses for predictors of survival with objective response as a time-dependent covariate in the REFLECT trial
| Parameter | Multivariate analysis |
|
|---|---|---|
| HR (95% CI) | p value | |
| Macroscopic portal vein invasion (yes vs. no) | 1.366 (1.141–1.636) | 0.0007 |
| Baseline AFP (ng/mL) (<200 vs. ≥200) | 0.564 (0.483–0.659) | <0.0001 |
| No. of tumor sites at baseline (2 vs. 1) | 1.400 (1.180–1.662) | <0.0001 |
| No. of tumor sites at baseline (≥3 vs. 1) | 2.024 (1.659–2.469) | <0.0001 |
| Involved tumor in liver (yes vs. no) | 1.675 (1.203–2.332) | 0.0022 |
| Etiology HBV (yes vs. no) | 1.199 (1.031–1.395) | 0.0185 |
| Prior procedure for HCC (yes vs. no) | 0.844 (0.723–0.986) | 0.0323 |
| Treatment (LEN vs. SOR) | 0.855 (0.734–0.996) | 0.0439 |
| Objective response (yes vs. no) | 0.611 (0.490–0.762) | <0.0001 |
Cited from Kudo et al. [11]. HR, hazard ratio; CI, confidence interval; AFP, α-fetoprotein; HBV, hepatitis Bvirus; HCC, hepatocellular carcinoma; LEN, lenvatinib; SOR, sorafenib.